arrow
D

Duk-Woo Park

university of ulsan
H指数:78
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Edoxaban Antithrombotic Therapy in Diabetic Patients with Atrial Fibrillation and Stable Coronary Artery Disease: The EPIC-CAD Trial

依度沙班抗血栓治疗在合并心房颤动和稳定型冠状动脉疾病的糖尿病患者中的应用:EPIC-CAD试验

2026-09-030
OAAI
Quality of Life After Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Coronary Occlusions

经皮冠状动脉介入治疗或药物治疗慢性完全性冠状动脉闭塞后的生活质量

JACC
IF0
2026-04-080
PRE
The Asia Pacific Cardiovascular Research (ASPIRE) Network Facilitating and Advancing Regional Cardiovascular Clinical Trials
2025-10-010
OAAI
Long-Term Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior PCI

心房颤动且先前接受过PCI的患者长期抗栓治疗

JACC
IF0
2025-08-270
PRE
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial

高风险患者接受复杂经皮冠状动脉介入治疗时抗血小板治疗的时序调整:TAILORED-CHIP随机临床试验

2025-08-011
PRE
Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial

对糖尿病非血流限制性易损性动脉粥样硬化冠状动脉斑块的预防性经皮冠状动脉介入治疗:PREVENT试验

2025-05-290
PRE
Long-term outcomes of intravascular ultrasound-guided percutaneous coronary intervention versus coronary artery bypass grafting for multivessel coronary artery disease

多支血管冠状动脉疾病中,血管内超声引导的经皮冠状动脉介入治疗与冠状动脉旁路移植术的长期结局比较

HEART
IF4.4
2025-05-140
PRE
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
2024-12-054
PRE
Fully automated quantitative coronary angiography versus optical coherence tomography guidance for coronary stent implantation (FLASH): Study protocol for a randomized controlled noninferiority trial
2024-09-010
PRE
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
2024-08-014
OAAI